| Name | Title | Contact Details |
|---|
Reliable Controls manufactures simple, flexible, sustainable building automation solutions that balance comfort and efficiency while reducing greenhouse gas emissions in buildings around the world. Our goal to help others achieve their goals begins by listening. We hear the World Green Building Councils call to businesses, organizations, cities, states, and regions to reach net-zero operation by 2050. The next 30 years are critical. In the world of building automation systems, that means you want products that are built responsibly and built to last. Reliable Controls technology is backward compatible, better by design, and supported by responsible recycling. Install our controllers now, and they will thrive for decades. Thats a sustainable return on investment. This dedication to multigenerational success is unique to our brand and reflects our pledge to sustainability. Its with purpose that we refer to our lineup of controllers or sensors as a family; each generation adds value, and nothing is rendered obsolete. We also take great pride in creating a healthy, sustainable working environment for our employees—as evidenced in our Canadas Greenest Employer Award honors in 2020.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Spray Foam Insulation Systems
OMi Cranes provides one of the few 100% turnkey solutions for your overhead lifting needs. We are a true overhead crane manufacturer, not just an assembler of others components. Whether providing a standard offering or completely customized solution, we know what works to fit your needs and budget. With over 30 years of industry experience, we provide the reliability for customers depend on. OMi Crane Systems, Inc. is a active member of Crane Manufacturers Association of America (CMAA). CMAA is an affiliate of the United States Division of Material Handling Industry (MHI). OMi Crane Systems, Inc. builds cranes to comply with OSHA standards, as well as CMAA and NEC specifications.
With a history of over 25 years, Ceto has forged enduring partnerships with over 2,000 regional and community banks and credit unions nationwide, igniting their profitability and growth. Our unwavering commitment lies in empowering financial institutions with cutting-edge intelligence and transformative solutions, elevating shareholder value, and fostering thriving, prosperous communities. Discover more at ceto.com or dial 866.227.1361 to embark on a transformative journey.